发明名称 ANDROGEN RECEPTOR MODULATOR FOR TREATMENT OF PROSTATE CANCER AND ANDROGEN RECEPTOR-ASSOCIATED DISEASES
摘要 PROBLEM TO BE SOLVED: To provide a series of compounds that modulate the function of the nuclear hormone receptors, especially the androgen receptor.SOLUTION: The present invention relates to hydantoin compounds, methods of using such compounds in the treatment of androgen receptor-associated conditions, such as age-related diseases, for example, prostate cancer, and to pharmaceutical compositions containing such compounds. In an embodiment, a pharmaceutical composition includes a therapeutically effective amount of a compound according to the formula II, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent, or adjuvant. The present invention provides a series of compounds that modulate the function of the nuclear hormone receptors, especially the androgen receptor. These compounds can cause disappearance of prostate cancer cells and tumors.
申请公布号 JP2014133755(A) 申请公布日期 2014.07.24
申请号 JP20140083382 申请日期 2014.04.15
申请人 REGENTS OF THE UNIV OF CALIFORNIA 发明人 JUNG MICHAEL E;SAWYERS CHARLES L;OUK SAMEDY;TRAN CHRIS;WONGVIPAT JOHN
分类号 C07D401/04;A61K9/08;A61K9/10;A61K9/14;A61K9/20;A61K9/48;A61K31/4439;A61K47/02;A61K47/20;A61K47/34;A61K47/38;A61P35/00;A61P43/00 主分类号 C07D401/04
代理机构 代理人
主权项
地址
您可能感兴趣的专利